Treatment of Systemic Mastocytosis With Tamoxifen

Location:

Rochester, Minn.

Trial status:
Open for Enrollment
Why is this study being done?

Not desired

Who is eligible to participate?

Inclusion Criteria: - Systemic Mastocytosis Exclusion Criteria: - Current treatment with Imatinib mesylate, cladribine or interferon alpha.

Last updated:
1/8/2014
NCT ID:
NCT01334996
IRB Number:
2506-04